Why BGPT?
logo

Review Papers Claim by Claim

Check each claim against its experiments, reported results, scope, and stated limitations.Know what the science actually supports before you trust the answer.

Press Enter ↵ to start review



    Explore by Goal












     Quick Explanation


    What this paper adds (mechanistically)
    • Direct interaction hubs: the RAD51 paralog complexes BCDX2 and CX3 contact BRCA2 at (i) BRC repeats (notably BRC1–2) and (ii) the BRCA2 DNA-binding domain, supported by amylose pulldowns and yeast three-hybrid mapping.
    • RAD51B is the key structural element for BRCA2 binding: BRCA2 interacts with the C-terminal domain (CTD) of RAD51B rather than its N-terminal domain (NTD).
    • A critical motif: mutation of a solvent-exposed FxxA motif (RAD51B F78A) abolishes BRCA2–RAD51B interactions, while preserving RAD51B’s interaction with its BCDX2 partners (RAD51C).
    • Functional consequence: expressing only RAD51B’s NTD or CTD fails to rescue IR-induced RAD51 foci, while RAD51B F78A yields an intermediate reduction in foci formation.
    Overall: the work advances a more specific protein-protein interface model linking RAD51 paralog complexes to BRCA2, moving from “genetic epistasis” toward “where and how they touch.”



     Long Explanation


    Paper Review: RAD51 Paralogs and RAD51 Paralog Complexes BCDX2 and CX3 Interact with BRCA2
    Preprint DOI: 10.1101/2024.10.10.617680
    Date in record: Oct 11, 2024
    Key mechanisms the paper supports
    • BRCA2 contacts both paralog complexes via BRC1–2: Yeast three-hybrid (Y3H) mapping shows interactions between BRCA2 BRC1–2 and canonical RAD51 paralogs, and the signal tracks with amylose pulldown trends where RAD51C is comparatively weak/absent.
    • BRCA2 also contacts the RAD51-paralog DNA-binding domain: beyond BRC repeats, the BRCA2 DNA-binding domain (DBD) fragment pulled down the RAD51 paralogs (notably RAD51B and RAD51D) in amylose pulldowns.
    • RAD51B–BRCA2 interface is on RAD51B CTD (not NTD): RAD51B CTD is sufficient to mediate BRCA2 interactions, while RAD51B NTD shows little/no recovery in BRCA2 domain pulldowns.
    • An FxxA motif is necessary for RAD51B–BRCA2 binding: the RAD51B FxxA motif mutation F78A abrogates BRCA2-domain pulldown of RAD51B, while preserving RAD51B–RAD51C interactions (complex integrity).
    • RAD51 foci requires full-length RAD51B (NTD + CTD): expressing only RAD51B NTD or CTD in RAD51B knockout cells fails to restore IR-induced RAD51 foci rates to WT. RAD51B F78A produces an intermediate phenotype.
    Visualization 1 — RAD51 foci rescue after 4 Gy
    The paper quantifies the percentage of RAD51-foci positive nuclei after IR (threshold defined in the paper as “≤5 foci/nucleus” per their wording). Below uses the numeric values explicitly stated in the manuscript text.
    Visualization 2 — Fold-change in foci positivity (4 Gy vs spontaneous)
    This quantifies how strongly each construct boosts IR-induced foci relative to its spontaneous baseline. Values computed directly from the explicitly stated percentages.
    Visualization 3 — Hypothesis-to-evidence mapping (direct interface → phenotype)
    A compact evidence chain: (1) pulldown + domain mapping → (2) directness via Y3H → (3) motif/CTD dependence → (4) foci phenotype with complementation/mutant.
    Skeptical critique (what’s strong vs what remains uncertain)
    Strengths (aligned measurements)
    • Multiple orthogonal assays support the same interface concept: amylose pulldowns (protein capture), domain mapping (which region binds), Y3H (directness), motif mutagenesis (mechanism), and cell-based RAD51 foci rescue (functional linkage).
    Potential limitations / blind spots
    • Bridging risk in pulldowns: because paralogs and BRCA2 are DNA-binding proteins, the authors use Benzonase treatment to reduce nucleic-acid-mediated bridging, but protein bridging from endogenous extract proteins can still, in principle, confound capture. The manuscript explicitly discusses this concern and uses Y3H to address directness.
    • RAD51C appears weak/absent in pulldowns, yet Y3H shows weaker growth: the paper suggests this mismatch may reflect RAD51C indirectly depending on co-expressed complex partners in yeast and/or limitations of the pulldown detection. However, this creates an uncertainty about how direct RAD51C–BRCA2 binding is in the tested contexts.
    • Functional endpoint is a proxy (foci) rather than direct HR outcome: the IR-induced RAD51 foci phenotype establishes a link to RAD51 recruitment/assembly or stability, but does not directly measure HR frequency, strand invasion, or fork restart. (The manuscript uses foci quantification as its endpoint for the RAD51B domain/motif experiments.)
    • Mutant interpretation: F78A could affect RAD51B–BRCA2 directly or via altered RAD51 (bridging) relationships: the paper acknowledges that F78A might disrupt a direct BRCA2 interface, or it might impair BRCA2 binding indirectly if BRCA2–RAD51B binding is mediated through RAD51 interactions. This is a key “unknown mechanism” remaining after the binding data.
    What would most disprove or substantially modify their model
    • Direct atomic interface mapping is missing: if future structural work (co-crystal/cryoEM of a complete BRCA2 fragment with the RAD51-paralog component in the relevant state) shows the CTD and FxxA do not form the hypothesized interface, the motif-based mechanistic claim would be revised. The present work relies on domain logic, motif exposure reasoning, and mutagenesis.
    • HR functional assays would be decisive: if HR reporter assays or replication-stress HR readouts show no dependence on CTD+motif (beyond RAD51 foci), then the “interface → HR coordination” interpretation would need to be narrowed from mechanistic regulator to recruitment marker only.
    Concise take-home (with confidence)
    Most supported claim
    RAD51B’s CTD and an FxxA motif (F78A) are required for BRCA2 binding in the tested binding assays, and full-length RAD51B is needed to efficiently generate IR-induced RAD51 foci in RAD51B knockout cells.
    Moderate confidence claim
    The interfaces are mechanistically responsible for coordinated RAD51 filament formation/stabilization in HR, but the current functional endpoint in this study segment is RAD51 foci rather than HR frequency or fork-restart readouts; thus the “how exactly this changes HR biochemistry” step is not fully closed.
    Bespoke BGPT follow-ups (author-centric and mechanism-centric)
    Author Reviews (bespoke BGPT links)


    Feedback:    

    Updated: March 28, 2026

     BGPT Paper Review


    Study Novelty

    90%

    The core novelty is moving from genetic/phenotypic relationships (paralogs epistatic with BRCA2) to a mapped, motif- and domain-resolved protein–protein interface model implicating BRCA2 BRC repeats/DBD and identifying an RAD51B CTD FxxA motif as required for BRCA2 binding, then linking this to RAD51 foci rescue outcomes in complemented knockout cells.


    Scientific Quality

    70%

    Strengths include multi-assay triangulation (pulldown + domain mapping + Y3H directness + motif mutagenesis + cellular foci endpoint). Skeptical red flags: binding evidence is largely derived from heterologous expression/co-expression contexts that can still permit protein bridging; functional readouts in the domain/motif section use RAD51 foci as a proxy rather than direct HR frequency/fork restart. The RAD51C “weakness” mismatch between pulldown and Y3H suggests context-dependent or indirect effects are not fully resolved.


    Study Generality

    60%

    The results are specific to human RAD51 paralog complexes BCDX2/CX3, BRCA2 domains (BRC repeats/DBD), and an RAD51B FxxA motif, with functional endpoint limited to RAD51 foci under IR in U2OS constructs. General HR-stage claims could strengthen with HR-frequency and/or fork restart measurements in additional contexts, which are not shown in the provided text.


    Study Usefulness

    80%

    For mechanistic users: it provides testable interface components (BRCA2 BRC1–2 and DBD; RAD51B CTD; RAD51B FxxA/F78) and a concrete mutant (F78A) linked to a cell phenotype (intermediate foci rescue). That can guide follow-up experiments aiming to quantify HR outcomes and to resolve whether RAD51C directly contacts BRCA2.


    Study Reproducibility

    50%

    The Methods section is fairly detailed about constructs, tags, and assay types (amylose pulldowns with 2XMBP-BRCA2, Benzonase treatment; Y3H workflow; U2OS RAD51B KO complementation; IR-induced immunofluorescence foci quantification). However, reproducibility is weakened by reliance on co-expression and by the absence of provided raw blinding/replicate-count details in the excerpted text; also, critical quantitative results shown are limited and not accompanied here by full uncertainties.


    Explanatory Depth

    60%

    The paper achieves mechanistic depth for where binding occurs (BRCA2 BRC repeats and DBD; RAD51B CTD) and for what motif is necessary (FxxA, F78A). The explanatory gap remains on how this interface changes the downstream biochemical steps of RAD51 filament formation/HR beyond RAD51 foci as a proxy, and on resolving RAD51C’s directness across assay contexts.


    🎁 Authors: Collect 181 Free Science Tokens (≈ $18.1 USD)

    Claim My Author Tokens

    Use for 45 days of free BGPT access (4 tokens = 1 day) or trade/sell (≈ $18.1 USD)

     Top Data Sources ExportMCP


     Analysis Wizard



    Extract the reported RAD51 foci percentages from the paper text and compute spontaneous→IR fold-changes and rank ordering, then output Plotly-ready arrays for comparative figures.



     Hypothesis Graveyard


    A pure “direct-contact-only” model (BRCA2 binds each paralog independently with fixed stoichiometry) is weakened because the paper reports RAD51C minimal/absent in pulldowns and proposes partner-mediated bridging as a likely explanation.


    A “motif affects only BRCA2 binding” model is incomplete because the paper indicates uncertainty whether F78A disrupts direct BRCA2 engagement or indirectly alters RAD51-mediated connections; this uncertainty can falsify any strict direct-only causal story without additional interface validation.

     Science Art


    Paper Review: RAD51 Paralogs and RAD51 Paralog Complexes BCDX2 and CX3 Interact with BRCA2 Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT






     Trending